Major physical and psychological harms of methamphetamine use
The DOI matches its Crossref record; 117 of the 117 references it cites were found in a registry or an index.
Abstract
Issues . The major physical and psychological health effects of methamphetamine use, and the factors associated with such harms. Approach . Comprehensive review. Key Findings . Physical harms reviewed included toxicity and mortality, cardiovascular/cerebrovascular pathology, dependence and blood‐borne virus transmission. Psychological harms include methamphetamine psychosis, depression, suicide, anxiety and violent behaviours. Implications . While high‐profile health consequences, such as psychosis, are given prominence in the public debate, the negative sequelae extend far beyond this. This is a drug class that causes serious heart disease, has serious dependence liability and high rates of suicidal behaviours. Conclusion . The current public image of methamphetamine does not portray adequately the extensive, and in many cases insidious, harms caused.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Furthermore, commonplace withdrawal symptoms like depression and anxiety are often already part of the typical highs and lows experienced with regular MA (70) or cocaine use (71).”
From Clinical management of psychostimulant withdrawal: review of the evidence (2023) · cites this paper as [70]
In the citing paper
“Psychostimulants are a unique group of substances because they are more likely to induce psychosis than other illicit drugs.14”
From Protocol for a systematic review of psychological treatment for methamphetamine use: An analysis of methamphetamine use and mental health symptom outcomes (2017) · cites this paper as [14]
In the citing paper
“Although vulnerability to psychotic symptoms differs among people who use MA, these symptoms are more apparent in people who use MA on a regular basis.14”
From Protocol for a systematic review of psychological treatment for methamphetamine use: An analysis of methamphetamine use and mental health symptom outcomes (2017) · cites this paper as [14]
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR)
American Psychiatric Association (2000) · doi:10.1176/appi.books.9780890423349 · Cited by 11,069
The Pharmacological Basis of Therapeutics
(1976) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/33.4.373a · Cited by 8,209
Regier, D. A. (1990) · JAMA · doi:10.1001/jama.1990.03450190043026 · Cited by 3,962
Abstinence Symptomatology and Psychiatric Diagnosis in Cocaine Abusers: Clinical Observations
Gawin, F. H. (1986) · Archives of General Psychiatry · doi:10.1001/archpsyc.1986.01800020013003 · Cited by 1,151
Association of Dopamine Transporter Reduction With Psychomotor Impairment in Methamphetamine Abusers
Volkow, N. D., Chang, L., Wang, G.-J., Fowler, J. S., Leonido-Yee, M., Franceschi, D., Sedler, M. J., Gatley, S. J., Hitzemann, R., Ding, Y.-S., et al. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.3.377 · Cited by 984
Volkow, N. D., Chang, L., Wang, G.-J., Fowler, J. S., Ding, Y.-S., Sedler, M., Logan, J., Franceschi, D., Gatley, J., Hitzemann, R., et al. (2001) · American Journal of Psychiatry · doi:10.1176/appi.ajp.158.12.2015 · Cited by 916 · cited 1×
“evidence of remission in the months following cessation of methamphetamine use [94,95].”
BackgroundCardiovascular complications of cocaine use
Lange, R. A., & Hillis, L. D. (2001) · New England Journal of Medicine · doi:10.1056/nejm200108023450507 · Cited by 810
Loss of Dopamine Transporters in Methamphetamine Abusers Recovers with Protracted Abstinence
Volkow, N. D., Chang, L., Wang, G.-J., Fowler, J. S., Franceschi, D., Sedler, M., Gatley, S. J., Miller, E., Hitzemann, R., Ding, Y.-S., et al. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-23-09414.2001 · Cited by 754
Risk factors for HIV infection among men who have sex with men.
Koblin, B. A., Husnik, M. J., Colfax, G., Huang, Y., Madison, M., Mayer, K., Barresi, P. J., Coates, T. J., Chesney, M. A., & Buchbinder, S. (2006) · AIDS · doi:10.1097/01.aids.0000216374.61442.55 · Cited by 678
The Pharmacological. Basis of Therapeutics
Lee, L. E. (1955) · American Journal of Clinical Pathology · doi:10.1093/ajcp/25.12.1401a · Cited by 532
Psychiatric Symptoms in Methamphetamine Users
Zweben, J. E., Cohen, J. B., Christian, D., Galloway, G. P., Salinardi, M., Parent, D., Iguchi, M., & Methamphetamine Treatment Project (2004) · The American Journal on Addictions · doi:10.1080/10550490490436055 · Cited by 468
The nature, time course and severity of methamphetamine withdrawal
McGregor, C., Srisurapanont, M., Jittiwutikarn, J., Laobhripatr, S., Wongtan, T., & White, J. M. (2005) · Addiction · doi:10.1111/j.1360-0443.2005.01160.x · Cited by 458 · cited 1×
“Withdrawal symptoms consist of fatigue, lethargy, sleep disturbances, appetite disturbances, depressed mood, irritability, psychomotor retardation or agitation and strong cravings for the drug [40 – 42].”
BackgroundMethamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons
RIPPETH, J. D., HEATON, R. K., CAREY, C. L., MARCOTTE, T. D., MOORE, D. J., GONZALEZ, R., WOLFSON, T., GRANT, I., & GROUP, T. H. (2004) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617704101021 · Cited by 435
The prevalence of psychotic symptoms among methamphetamine users
McKetin, R., McLaren, J., Lubman, D. I., & Hides, L. (2006) · Addiction · doi:10.1111/j.1360-0443.2006.01496.x · Cited by 393
Self-citationLondon, E. D., Simon, S. L., Berman, S. M., Mandelkern, M. A., Lichtman, A. M., Bramen, J., Shinn, A. K., Miotto, K., Learn, J., Dong, Y., et al. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.1.73 · Cited by 384
Magnetic Resonance Spectroscopy
Gujar, S. K., Maheshwari, S., Bj??rkman-Burtscher, I., & Sundgren, P. C. (2005) · Journal of Neuro-Ophthalmology · doi:10.1097/01.wno.0000177307.21081.81 · Cited by 380
(1998) · Europe PMC (PubMed Central) · Cited by 336
Coffin, P. O., Galea, S., Ahern, J., Leon, A. C., Vlahov, D., & Tardiff, K. (2003) · Addiction · doi:10.1046/j.1360-0443.2003.00376.x · Cited by 334
Westover, A. N., McBride, S., & Haley, R. W. (2007) · Archives of General Psychiatry · doi:10.1001/archpsyc.64.4.495 · Cited by 324
Methamphetamine and cardiovascular pathology: a review of the evidence
Kaye, S., McKetin, R., Duflou, J., & Darke, S. (2007) · Addiction · doi:10.1111/j.1360-0443.2007.01874.x · Cited by 319
Self-citationStimulant psychosis: systematic review
Curran, C., Byrappa, N., & McBride, A. (2004) · British Journal of Psychiatry · doi:10.1192/bjp.185.3.196 · Cited by 318
Pre-morbid characteristics and co-morbidity of methamphetamine users with and without psychosis
CHEN, C.-K., LIN, S.-K., SHAM, P. C., BALL, D., LOH, E.-W., HSIAO, C.-C., CHIANG, Y.-L., REE, S.-C., LEE, C.-H., & MURRAY, R. M. (2003) · Psychological Medicine · doi:10.1017/s0033291703008353 · Cited by 295 · cited 3×
“pear to be remarkably common among regular users [57,66,69 – 73].”
BackgroundBrain Serotonin Transporter Density and Aggression in Abstinent Methamphetamine Abusers
Sekine, Y., Ouchi, Y., Takei, N., Yoshikawa, E., Nakamura, K., Futatsubashi, M., Okada, H., Minabe, Y., Suzuki, K., Iwata, Y., et al. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.1.90 · Cited by 287
Neuropsychological function and delay discounting in methamphetamine-dependent individuals
Hoffman, W. F., Moore, M., Templin, R., McFarland, B., Hitzemann, R. J., & Mitchell, S. H. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0494-0 · Cited by 286
Julien, R. M. (1975) · Cited by 269
Methamphetamine-Related Deaths in San Francisco: Demographic, Pathologic, and Toxicologic Profiles
Karch, S., Stephens, B., & Ho, C.-H. (1999) · Journal of Forensic Sciences · doi:10.1520/jfs14464j · Cited by 248
Cocaine-Induced Psychosis: (324222004-013)
Brady, K. T., Lydiard, R. B., Malcolm, R., & Ballenger, J. C. (1992) · PsycEXTRA Dataset · doi:10.1037/e324222004-013 · Cited by 243
Chang, L., Smith, L. M., LoPresti, C., Yonekura, M. L., Kuo, J., Walot, I., & Ernst, T. (2004) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2004.06.004 · Cited by 243
Choosing a cut-off on the Severity of Dependence Scale (SDS) for amphetamine users
Topp, L., & Mattick, R. P. (1997) · Addiction · doi:10.1046/j.1360-0443.1997.9278397.x · Cited by 242
Sekine, Y., Minabe, Y., Ouchi, Y., Takei, N., Iyo, M., Nakamura, K., Suzuki, K., Tsukada, H., Okada, H., Yoshikawa, E., et al. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.9.1699 · Cited by 241
Perfusion MRI and computerized cognitive test abnormalities in abstinent methamphetamine users
Chang, L., Ernst, T., Speck, O., Patel, H., DeSilva, M., Leonido-Yee, M., & Miller, E. N. (2002) · Psychiatry Research: Neuroimaging · doi:10.1016/s0925-4927(02)00004-5 · Cited by 224
Relapse of Paranoid Psychotic State in Methamphetamine Model of Schizophrenia
Sato, M., Numachi, Y., & Hamamura, T. (1992) · Schizophrenia Bulletin · doi:10.1093/schbul/18.1.115 · Cited by 221
Stroke and Cocaine or Amphetamine Use
Petitti, D. B., Sidney, S., Quesenberry, C., & Bernstein, A. (1998) · Epidemiology · doi:10.1097/00001648-199811000-00005 · Cited by 219
Cause and Manner of Death in Fatalities Involving Methamphetamine
Logan, B., Fligner, C., & Haddix, T. (1998) · Journal of Forensic Sciences · doi:10.1520/jfs16085j · Cited by 215
Buchacz, K., McFarland, W., Kellogg, T. A., Loeb, L., Holmberg, S. D., Dilley, J., & Klausner, J. D. (2005) · AIDS · doi:10.1097/01.aids.0000180794.27896.fb · Cited by 214
Methamphetamine and the expanding complications of amphetamines.
Albertson, T. E., Derlet, R. W., & Hoozen, B. E. V. (1999) · PubMed Central · Cited by 209
Drugs and sexual effects: role of drug type and gender
Rawson, R. A., Washton, A., Domier, C. P., & Reiber, C. (2002) · Journal of Substance Abuse Treatment · doi:10.1016/s0740-5472(01)00215-x · Cited by 209 · cited 2×
“Indeed, it has been reported that approximately half of users are more likely to engage in high-risk sexual activities while intoxicated with methamphetamine [45].”
BackgroundEnlarged striatum in abstinent methamphetamine abusers: A possible compensatory response
Chang, L., Cloak, C., Patterson, K., Grob, C., Miller, E. N., & Ernst, T. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.01.039 · Cited by 205
The Association of Methamphetamine Use and Cardiomyopathy in Young Patients
Yeo, K.-K., Wijetunga, M., Ito, H., Efird, J. T., Tay, K., Seto, T. B., Alimineti, K., Kimata, C., & Schatz, I. J. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.01.024 · Cited by 204
Mechanisms of methamphetamine-induced dopaminergic neurotoxicity
Riddle, E. L., Fleckenstein, A. E., & Hanson, G. R. (2006) · The AAPS Journal · doi:10.1007/bf02854914 · Cited by 199
Levels and correlates of polydrug use among heroin users and regular amphetamine users
Darke, S., & Hall, W. (1995) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(95)01171-9 · Cited by 197
Self-citationMethamphetamine use among young adults: Health and social consequences
Sommers, I., Baskin, D., & Baskin-Sommers, A. (2006) · Addictive Behaviors · doi:10.1016/j.addbeh.2005.10.004 · Cited by 197
Suicidal Ideation and Suicide Attempts Among Australian Adults
Pirkis, J., Burgess, P., & Dunt, D. (2000) · Crisis · doi:10.1027//0227-5910.21.1.16 · Cited by 181
The pharmacology of cocaethylene in humans following cocaine and ethanol administration
Harris, D. S., Everhart, E. T., Mendelson, J. E., & Jones, R. T. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(03)00200-x · Cited by 174
Current Research on Methamphetamine-Induced Neurotoxicity: Animal Models of Monoamine Disruption
Kita, T., Wagner, G. C., & Nakashima, T. (2003) · Journal of Pharmacological Sciences · doi:10.1254/jphs.92.178 · Cited by 173
IMAM, S. Z., EL‐YAZAL, J., NEWPORT, G. D., ITZHAK, Y., CADET, J. L., SLIKKER, W., & ALI, S. F. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03646.x · Cited by 173
Affective and predatory violence: A bimodal classification system of human aggression and violence
McEllistrem, J. E. (2004) · Aggression and Violent Behavior · doi:10.1016/j.avb.2003.06.002 · Cited by 172
Mortality amongst Illicit Drug Users: Epidemiology, Causes and Intervention
Darke, S., Degenhardt, L., & Mattick, R. (2006) · Cambridge University Press eBooks · doi:10.1017/cbo9780511543692 · Cited by 168
Self-citationBartlett, E. (1997) · Neuropsychopharmacology · doi:10.1016/s0893-133x(96)00164-9 · Cited by 160
Methamphetamine abuse and emergency department utilization.
Richards, J. R., Bretz, S. W., Johnson, E. B., Turnipseed, S. D., Brofeldt, B. T., & Derlet, R. W. (1999) · Europe PMC (PubMed Central) · Cited by 157
Chen, C.-K., Lin, S.-K., Sham, P. C., Ball, D., Loh, E.-W., & Murray, R. M. (2005) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.30187 · Cited by 156
Turnipseed, S. D., Richards, J. R., Kirk, J. D., Diercks, D. B., & Amsterdam, E. A. (2003) · Journal of Emergency Medicine · doi:10.1016/s0736-4679(03)00031-3 · Cited by 155
Stimulant Psychosis: Symptom Profile and Acute Clinical Course
Harris, D., & Batki, S. L. (2000) · The American Journal on Addictions · doi:10.1080/10550490050172209 · Cited by 152
Hepatitis C augments cognitive deficits associated with HIV infection and methamphetamine
Cherner, M., Letendre, S., Heaton, R. K., Durelle, J., Marquie-Beck, J., Gragg, B., Grant, I., & the HIV Neurobehavioral Research Center Group (2005) · Neurology · doi:10.1212/01.wnl.0000158328.26897.0d · Cited by 150
Psychological morbidity and route of administration among amphetamine users in Sydney, Australia
HALL, W., HANDO, J., DARKE, S., & ROSS, J. (1996) · Addiction · doi:10.1046/j.1360-0443.1996.9118110.x · Cited by 146
Self-citationCadet, J. L., Jayanthi, S., & Deng, X. (2005) · Neurotoxicity Research · doi:10.1007/bf03033973 · Cited by 146
Neurocognitive performance of methamphetamine users discordant for history of marijuana exposure
González, R., Rippeth, J. D., Carey, C. L., Heaton, R. K., Moore, D. J., Schweinsburg, B. C., Cherner, M., & Grant, I. (2004) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2004.04.014 · Cited by 146
Crystal Methamphetamine‐Associated Cardiomyopathy: Tip of the Iceberg?
Wijetunga, M., Seto, T., Lindsay, J., & Schatz, I. (2003) · Journal of Toxicology: Clinical Toxicology · doi:10.1081/clt-120026521 · Cited by 145
The relationship between crystalline methamphetamine use and methamphetamine dependence
McKetin, R., Kelly, E., & McLaren, J. (2006) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2006.04.007 · Cited by 145
Self-citationPsychosis and drug dependence: results from a national survey of prisoners
Farrell, M., Boys, A., Bebbington, P., Brugha, T., Coid, J., Jenkins, R., Lewis, G., Meltzer, H., Marsden, J., Singleton, N., et al. (2002) · British Journal of Psychiatry · doi:10.1192/bjp.181.5.393 · Cited by 140
Iwanami, A., Sugiyama, A., Kuroki, N., Toda, S., Kato, N., Nakatani, Y., Horita, N., & Kaneko, T. (1994) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1994.tb01541.x · Cited by 135
Utilization of Drug Treatment Programs by Methamphetamine Users: The Role of Social Stigma
Semple, S. J., Grant, I., & Patterson, T. L. (2005) · The American Journal on Addictions · doi:10.1080/10550490591006924 · Cited by 131
Karch's Pathology of Drug Abuse
Karch, S. B. (1996) · Thammasat University Digital Collections · Cited by 128
SEIDEN, L. S., COMMINS, D. L., VOSMER, G., AXT, K., & MAREK, G. (1988) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1988.tb42104.x · Cited by 126
Methamphetamine and ethanol interactions in humans*
Mendelson, J., Jones, R. T., Upton, R., & Jacob, P. (1995) · Clinical Pharmacology & Therapeutics · doi:10.1016/0009-9236(95)90041-1 · Cited by 125
Woods, S. P., HIV Neurobehavioral Research Center Group, Rippeth, J. D., Conover, E., Gongvatana, A., Gonzalez, R., Carey, C. L., Cherner, M., Heaton, R. K., & Grant, I. (2005) · Neuropsychology · doi:10.1037/0894-4105.19.1.35 · Cited by 120
The ratio of non‐fatal to fatal heroin overdose
Darke, S., Mattick, R. P., & Degenhardt, L. (2003) · Addiction · doi:10.1046/j.1360-0443.2003.00474.x · Cited by 118
Self-citationMortality Amongst Illicit Drug Users. Epidemiology, Causes and Intervention
Rossow, I. M. (2007) · Addiction · doi:10.1111/j.1360-0443.2007.01924.x · Cited by 118
Relating Cocaine Blood Concentrations to Toxicity—an Autopsy Study of 99 Cases
Karch, S. B., Stephens, B. G., & Ho, C.-H. (1998) · Journal of Forensic Sciences · doi:10.1520/jfs16087j · Cited by 113
An Ethnographic Comparison of HIV Risk Behaviors Among Heroin and Methamphetamine Injectors
Zule, W. A., & Desmond, D. P. (1999) · The American Journal of Drug and Alcohol Abuse · doi:10.1081/ada-100101843 · Cited by 107
Psychosis among substance users
Thirthalli, J., & Benegal, V. (2006) · Current Opinion in Psychiatry · doi:10.1097/01.yco.0000218593.08313.fd · Cited by 102
The effect of persistence of cocaine use on 12-month outcomes for the treatment of heroin dependence
Williamson, A., Darke, S. G., Ross, J. E., & Teesson, M. (2005) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2005.08.010 · Cited by 102
Self-citationSexual and Injection Risk among Women who Inject Methamphetamine in San Francisco
Lorvick, J., Martinez, A. N., Gee, L., & Kral, A. H. (2006) · Journal of Urban Health · doi:10.1007/s11524-006-9039-4 · Cited by 99
Morin, S. F., Steward, W. T., Charlebois, E. D., Remien, R. H., Pinkerton, S. D., Johnson, M. O., Rotheram-Borus, M. J., Lightfoot, M., Goldstein, R. B., Kittel, L., et al. (2005) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000166375.16222.eb · Cited by 98
YUI, K., IKEMOTO, S., ISHIGURO, T., & GOTO, K. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb05178.x · Cited by 96
NORDAHL, T. E., Salo, R. E., Possin, K. L., Gibson, D. R., Flynn, N. M., Leamon, M. H., Galloway, G. P., Pfefferbaum, A., Spielman, D. M., Elfar Adalsteinsson, A., et al. (2002) · Psychiatry Research Neuroimaging · doi:10.1016/s0925-4927(02)00088-4 · Cited by 95
Differences between methamphetamine users and cocaine users in treatment
Copeland, A. L., & Sorensen, J. L. (2001) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(00)00164-2 · Cited by 94
Methamphetamine as a Risk Factor for Acute Aortic Dissection
Swalwell, C., & Davis, G. (1999) · Journal of Forensic Sciences · doi:10.1520/jfs14407j · Cited by 92
Clinical manifestations and prognostic features of acute methamphetamine intoxication.
Lan, K. C., Lin, Y., Yu, F. C., Lin, C. S., & Chu, P. (1998) · PubMed · Cited by 91
Non‐fatal cocaine overdose among injecting and non‐injecting cocaine users in Sydney, Australia
Kaye, S. S., & Darke, S. G. (2004) · Addiction · doi:10.1111/j.1360-0443.2004.00875.x · Cited by 86
Self-citationAcute Myocardial Infarction Associated With Amphetamine Use
Waksman, J. C., Taylor, R. N., Bodor, G. S., Daly, F. F. S., Jolliff, H. A., & Dart, R. C. (2001) · Mayo Clinic Proceedings · doi:10.4065/76.3.323 · Cited by 80
Sadek, J. R., Vigil, O., Grant, I., et al. (2006) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803390600659384 · Cited by 74
Zhu, B.-L., Oritani, S., Shimotouge, K., Shintani‐Ishida, K., Li, Q., Fujita, M., Ogawa, M., & Maeda, H. (2000) · Forensic Science International · doi:10.1016/s0379-0738(00)00281-4 · Cited by 74
Cardiovascular Responses Elicited by the “Binge” Administration of Methamphetamine
Varner, K. J., Ogden, B. A., Delcarpio, J. B., & Meleg-Smith, S. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.1.152 · Cited by 74
Burcham, J. L., Berry, G., Tindall, B., Cooper, D. A., Marmor, M., & Penny, R. (1989) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1989.tb136727.x · Cited by 74
Karch's Pathology of Drug Abuse
Milroy, C. (2002) · Journal of the Royal Society of Medicine · doi:10.1258/jrsm.95.5.262 · Cited by 72
Methamphetamine and MDMA (Ecstasy) Neurotoxicity: 'of Mice and Men'
Itzhak, Y., & Achat‐Mendes, C. (2004) · IUBMB Life · doi:10.1080/15216540410001727699 · Cited by 66
Cocaine-related fatalities in New South Wales, Australia 1993–2002
Darke, S. G., Kaye, S. S., & Duflou, J. A. (2004) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2004.07.004 · Cited by 63
Self-citationThe Effect of Recent Stimulant Use on Sustained Attention in HIV-Infected Adults
Levine, A. J., Hardy, D. J., Miller, E. N., Castellon, S. A., Longshore, D. L., & Hinkin, C. H. (2006) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803390490918066 · Cited by 63
Amphetamines and Related Stimulants: Chemical, Biological, Clinical, and Sociological Aspects
(2019) · CRC Press eBooks · doi:10.1201/9780429279843 · Cited by 62
Dalmau, A., Bergman, B., & Brismar, B. (1999) · European Psychiatry · doi:10.1016/s0924-9338(99)00234-5 · Cited by 62
Sokolov, B. P., & Cadet, J. L. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300891 · Cited by 59
Jaffe, C., Bush, K. R., Straits-Troster, K., Meredith, C., Romwall, L., Rosenbaum, G., Cherrier, M., & Saxon, A. J. (2005) · Journal of Addictive Diseases · doi:10.1300/j069v24n03_11 · Cited by 58
Caligiuri, M. P., & Buitenhuys, C. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300859 · Cited by 56
CLEMENS, K. J., McGREGOR, I. S., HUNT, G. E., & CORNISH, J. L. (2007) · Drug and Alcohol Review · doi:10.1080/09595230601036945 · Cited by 55
Injecting and non‐injecting cocaine use in Sydney, Australia: physical and psychological morbidity
KAYE, S., & DARKE, S. (2004) · Drug and Alcohol Review · doi:10.1080/09595230412331324518 · Cited by 53
Self-citationRelationship Between Methamphetamine Use and Risky Sexual Behavior in Adolescents
Yen, C. (2004) · The Kaohsiung Journal of Medical Sciences · doi:10.1016/s1607-551x(09)70101-9 · Cited by 50
Mortality amongst illicit drug users
(2006) · Mortality amongst Illicit Drug Users · doi:10.1017/cbo9780511543692.003 · Cited by 50
Cocaethylene Levels in Patients Who Test Positive for Cocaine
Brookoff, D., Rotondo, M. F., Shaw, L. M. J., Campbell, E. A., & §, L. F. (1996) · Annals of Emergency Medicine · doi:10.1016/s0196-0644(96)70266-4 · Cited by 48
Accidental drug-induced deaths due to opioids in Australia, 2013
Roxburgh, A., & Burns, L. (2017) · Cited by 48
Derlet, R. W., & Horowitz, B. Z. (1995) · Emergency Medicine Clinics of North America · doi:10.1016/s0733-8627(20)30588-5 · Cited by 47
A comparison of the harms associated with the injection of heroin and amphetamines
Kaye, S. S., & Darke, S. G. (2000) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(99)00102-7 · Cited by 46
Self-citationMethamphetamine Use and HIV Risk Among Substance-Abusing Offenders in California
Farabee, D. J., PRENDERGAST, M. L., & Cartier, J. (2002) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2002.10399966 · Cited by 46
An Australian profile on the use of cocaine
Hando, J., Flaherty, B., & Rutter, S. A. (1997) · Addiction · doi:10.1111/j.1360-0443.1997.tb03650.x · Cited by 45
Chronic methamphetamine increases fighting in mice
Sokolov, B. P., Schindler, C. W., & Cadet, J. L. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2003.11.006 · Cited by 44
Acute Myocardial Infarction Caused by Transnasal Inhalation of Amphetamine.
Huang, C., Wu, D. J., & Chen, K.-S. (1993) · Japanese Heart Journal · doi:10.1536/ihj.34.815 · Cited by 34
Validation of the amphetamine dependence syndrome and the SAmDQ.
Topp, L., & Mattick, R. P. (1997) · PubMed · Cited by 32
Characteristics of treatment provided for amphetamine use in New South Wales, Australia
McKETIN, R., KELLY, E., & INDIG, D. (2005) · Drug and Alcohol Review · doi:10.1080/09595230500290858 · Cited by 28
Self-citationWelder, A. A. (1992) · Toxicology Letters · doi:10.1016/0378-4274(92)90273-m · Cited by 23
DLUZEN, D. E., & MCDERMOTT, J. L. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1316.026 · Cited by 23
Relationship between Methamphetamine Use and Violent Behaviour, The
McKetin, R., McLaren, J., Riddell, S., & Robins, L. (2006) · BOCSAR NSW Crime and Justice Bulletins · Cited by 23
Self-citationMcMurrich, J. P. (1901) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1901.tb55048.x · Cited by 14
Sztajnkrycer, M. D., Hariharan, S. L., & Bond, G. R. (2002) · Pediatric Emergency Care · doi:10.1097/00006565-200208000-00004 · Cited by 13
Lexau, B. J., Nelson, D. B., & Hatsukami, D. K. (1998) · American Journal on Addictions · doi:10.3109/10550499808995638 · Cited by 9
Role of 131 I‐metaiodobenzylguanidine in the localization of suspected phaeochromocytomas
Khafagi, F. A., Mortimer, R. H., Egerton-Vernon, J., & Perry‐Keene, D. A. (1989) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1989.tb136728.x · Cited by 4
[Constant annual incidence of HIV infection among intravenous drug addicts].
Käll, K. I., & Olin, R. (1992) · PubMed · Cited by 2
Clinical Features of Adolescent Methamphetamine Abusers. Current Patterns of Methamphetamine Use.
Matsumoto, T., Tsuyoshi, K., & Takeuchi, N. (2000) · Cited by 2
Research works printed but not linked: 7
- McKetin R., 2005, The Sydney methamphetamine market: patterns of supply, use, personal harms and social consequences
- Brands B., 1998, Drugs and drug abuse
- Degenhardt L., 2007, 2005 cocaine and methamphetamine related drug‐induced deaths in Australia
- 10.1111/j.1360-0443.1997.tb02953.x · doi:10.1111/j.1360-0443.1997.tb02953.x · Paper page
- Graf K., 1977, MMPI changes in briefly hospitalised non‐narcotic drug users. Clinical observations, Arch Gen Psychiatry, 43, 107
- Brady KT, 1991, Cocaine‐induced psychosis, J Clin Psychiatry, 52, 509
- 10.1111/j.1521-0391.1998.tb00345.x · doi:10.1111/j.1521-0391.1998.tb00345.x
Cited by
Degenhardt, L., Charlson, F., Ferrari, A., Santomauro, D., Erskine, H., Mantilla-Herrara, A., Whiteford, H., Leung, J., Naghavi, M., Griswold, M., et al. (2018) · The Lancet Psychiatry · doi:10.1016/s2215-0366(18)30337-7 · Cited by 1,572
Epidemiology of suicide and the psychiatric perspective
Bachmann, S. (2018) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph15071425 · Cited by 1,377
“Cannabis did not constitute an independent risk factor, but cocaine and methamphetamine are related to suicide attempts in 20% of users and to suicidality in about two-thirds of users [111,121,122].”
BackgroundExtent of illicit drug use and dependence, and their contribution to the global burden of disease
Degenhardt, L., & Hall, W. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61138-0 · Cited by 1,303
Methamphetamine toxicity and messengers of death
Krasnova, I. N., & Cadet, J. L. (2009) · Brain Research Reviews · doi:10.1016/j.brainresrev.2009.03.002 · Cited by 589
Methamphetamine use: A comprehensive review of molecular, preclinical and clinical findings
Panenka, W. J., Procyshyn, R. M., Lecomte, T., MacEwan, G. W., Flynn, S. W., Honer, W. G., & Barr, A. M. (2013) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.11.016 · Cited by 432
“rrhythmias, valvular disease, hemorrhagic/ischemic strokes, and high incidence of myocardial infarction (Darke et al., 2008).”
Background
Metadata
- Authors
- DARKE, S., KAYE, S., McKETIN, R., & DUFLOU, J.
- Affiliations
- UNSW Sydney (AU)
- Sydney South West Area Health Service (AU)
- Corresponding author
- DARKE, SHANE
- Venue
- Drug and Alcohol Review
- Publisher
- Wiley
- Published
- 2008-05
- Volume
- 27
- Issue
- 3
- Pages
- 253-262
- ISSN
- 0959-5236 (ISSN-L)
- 1465-3362
- OpenAlex
- W2161516646
- Cited by
- 675
- References
- 117
- Citations by year
- 2026: 24 · 2025: 29 · 2024: 38 · 2023: 34 · 2022: 41 · 2021: 39 · 2020: 61 · 2019: 41 · 2018: 46 · 2017: 37 · 2016: 41 · 2015: 40 · 2014: 34 · 2013: 46 · 2012: 36
- FWCI
- 3.14
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Drug and Alcohol Review (publishedVersion)
- PubMed (publishedVersion)
- ANU Open Research (Australian National University) (submittedVersion)
- Funders
- Australian Government
- Topics
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Health Sciences › Medicine › Epidemiology › HIV, Drug Use, Sexual Risk
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
- Keywords
- methamphetamine, stimulant use, psychological harm, cardiovascular disease, cerebrovascular disease, drug addiction, blood-borne virus transmission, psychosis, depression, suicide, anxiety, violent behavior, mortality, risk factors
- MeSH terms
- Central Nervous System Stimulants, Heart Diseases, Humans, Methamphetamine, Illicit Drugs, Suicide, Self-Injurious Behavior, Amphetamine-Related Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.